444 related articles for article (PubMed ID: 38298192)
1. Diverse drug delivery systems for the enhancement of cancer immunotherapy: an overview.
Liu X; Cheng Y; Mu Y; Zhang Z; Tian D; Liu Y; Hu X; Wen T
Front Immunol; 2024; 15():1328145. PubMed ID: 38298192
[TBL] [Abstract][Full Text] [Related]
2. [Development of a Nano DDS for Cancer Immunotherapy Based on Llipid Nanoparticles].
Nakamura T
Yakugaku Zasshi; 2018; 138(12):1443-1449. PubMed ID: 30504656
[TBL] [Abstract][Full Text] [Related]
3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
4. Nano-, micro-, and macroscale drug delivery systems for cancer immunotherapy.
Huang P; Wang X; Liang X; Yang J; Zhang C; Kong D; Wang W
Acta Biomater; 2019 Feb; 85():1-26. PubMed ID: 30579043
[TBL] [Abstract][Full Text] [Related]
5. Redox-responsive nano-carriers as tumor-targeted drug delivery systems.
Raza A; Hayat U; Rasheed T; Bilal M; Iqbal HMN
Eur J Med Chem; 2018 Sep; 157():705-715. PubMed ID: 30138802
[TBL] [Abstract][Full Text] [Related]
6. Advanced nanotechnology: An arsenal to enhance immunotherapy in fighting cancer.
Cheng CT; Castro G; Liu CH; Lau P
Clin Chim Acta; 2019 May; 492():12-19. PubMed ID: 30711524
[TBL] [Abstract][Full Text] [Related]
7. [Development of Nano-DDS Carriers for Control of Spatial Distribution Using Multi-color Deep Imaging].
Kawakami S; Suga T
Yakugaku Zasshi; 2020; 140(5):633-640. PubMed ID: 32378663
[TBL] [Abstract][Full Text] [Related]
8. Emerging Strategies in Stimuli-Responsive Nanocarriers as the Drug Delivery System for Enhanced Cancer Therapy.
Saravanakumar K; Hu X; Ali DM; Wang MH
Curr Pharm Des; 2019; 25(24):2609-2625. PubMed ID: 31603055
[TBL] [Abstract][Full Text] [Related]
9. Mesoporous Silica Materials as an Emerging Tool for Cancer Immunotherapy.
Escriche-Navarro B; Escudero A; Lucena-Sánchez E; Sancenón F; García-Fernández A; Martínez-Máñez R
Adv Sci (Weinh); 2022 Sep; 9(26):e2200756. PubMed ID: 35866466
[TBL] [Abstract][Full Text] [Related]
10. Advances in Delivery of Chemotherapeutic Agents for Cancer Treatment.
Yadav A; Singh S; Sohi H; Dang S
AAPS PharmSciTech; 2021 Dec; 23(1):25. PubMed ID: 34907501
[TBL] [Abstract][Full Text] [Related]
11. Integration of nano drug-delivery system with cancer immunotherapy.
Nakamura T; Harashima H
Ther Deliv; 2017 Nov; 8(11):987-1000. PubMed ID: 29061103
[TBL] [Abstract][Full Text] [Related]
12. Drug Delivery Systems Based on Polymeric Micelles and Ultrasound: A Review.
Tanbour R; Martins AM; Pitt WG; Husseini GA
Curr Pharm Des; 2016; 22(19):2796-807. PubMed ID: 26898742
[TBL] [Abstract][Full Text] [Related]
13. Combining Nanomedicine and Immunotherapy.
Shi Y; Lammers T
Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
[TBL] [Abstract][Full Text] [Related]
14. An Iron Oxide Nanocarrier Loaded with a Pt(IV) Prodrug and Immunostimulatory dsRNA for Combining Complementary Cancer Killing Effects.
Hernández-Gil J; Cobaleda-Siles M; Zabaleta A; Salassa L; Calvo J; Mareque-Rivas JC
Adv Healthc Mater; 2015 May; 4(7):1034-42. PubMed ID: 25846677
[TBL] [Abstract][Full Text] [Related]
15. Mesoporous Silica Nanoparticles as Carriers for Biomolecules in Cancer Therapy.
Küçüktürkmen B; Rosenholm JM
Adv Exp Med Biol; 2021; 1295():99-120. PubMed ID: 33543457
[TBL] [Abstract][Full Text] [Related]
16. Drug delivery systems: entering the mainstream.
Allen TM; Cullis PR
Science; 2004 Mar; 303(5665):1818-22. PubMed ID: 15031496
[TBL] [Abstract][Full Text] [Related]
17. Surface protein-retractive and redox-degradable mesoporous organosilica nanoparticles for enhanced cancer therapy.
Yang G; Kim S; Oh JY; Kim D; Jin S; Choi E; Ryu JH
J Colloid Interface Sci; 2023 Nov; 649():1014-1022. PubMed ID: 37392681
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in drug delivery strategies for treatment of ovarian cancer.
Zahedi P; Yoganathan R; Piquette-Miller M; Allen C
Expert Opin Drug Deliv; 2012 May; 9(5):567-83. PubMed ID: 22452661
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in mesoporous silica nanoparticle-based targeted drug-delivery systems for cancer therapy.
Li Y; Deng G; Hu X; Li C; Wang X; Zhu Q; Zheng K; Xiong W; Wu H
Nanomedicine (Lond); 2022 Aug; 17(18):1253-1279. PubMed ID: 36250937
[TBL] [Abstract][Full Text] [Related]
20. Targeted Drug Delivery Systems and Their Therapeutic Applications in Cancer and Immune Pathological Conditions.
Iqbal J; Anwar F; Afridi S
Infect Disord Drug Targets; 2017; 17(3):149-159. PubMed ID: 28595539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
